Article
T cell engineering as therapy for cancer and HIV: our synthetic future
30 Sept 2015
Abstract excerpt
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the significant limitations associated with vaccine-based strategies in patients who are often immune compromised. Application of the emerging discipline of synthetic biology to cancer, which combines elements of genetic engineering and molecular biology to create new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
